Found: 117
Select item for more details and to access through your institution.
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06556-0
- By:
- Publication type:
- Article
Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50774-3
- By:
- Publication type:
- Article
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06556-0
- By:
- Publication type:
- Article
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adl2055
- By:
- Publication type:
- Article
Developing a Prototype Pathogen Plan and Research Priorities for the Alphaviruses.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S414, doi. 10.1093/infdis/jiac326
- By:
- Publication type:
- Article
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41171-3
- By:
- Publication type:
- Article
A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40187-z
- By:
- Publication type:
- Article
A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 696, p. 1, doi. 10.1126/scitranslmed.ade8273
- By:
- Publication type:
- Article
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1135841
- By:
- Publication type:
- Article
Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 5, p. 298, doi. 10.1093/jpids/piad019
- By:
- Publication type:
- Article
Glycan masking in vaccine design: Targets, immunogens and applications.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1126034
- By:
- Publication type:
- Article
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1135841
- By:
- Publication type:
- Article
Nebulized mRNA‐Encoded Antibodies Protect Hamsters from SARS‐CoV‐2 Infection.
- Published in:
- Advanced Science, 2022, v. 9, n. 34, p. 1, doi. 10.1002/advs.202202771
- By:
- Publication type:
- Article
Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods.
- Published in:
- PLoS Computational Biology, 2022, v. 18, n. 12, p. 1, doi. 10.1371/journal.pcbi.1010230
- By:
- Publication type:
- Article
Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1040836
- By:
- Publication type:
- Article
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 665, p. 1, doi. 10.1126/scitranslmed.abo6160
- By:
- Publication type:
- Article
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 1270, doi. 10.1038/s41587-022-01232-2
- By:
- Publication type:
- Article
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31615-7
- By:
- Publication type:
- Article
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31142-5
- By:
- Publication type:
- Article
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30865-9
- By:
- Publication type:
- Article
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 5, p. 1, doi. 10.1371/journal.ppat.1010518
- By:
- Publication type:
- Article
Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28757-z
- By:
- Publication type:
- Article
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.808047
- By:
- Publication type:
- Article
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 1, p. 1, doi. 10.1371/journal.ppat.1010179
- By:
- Publication type:
- Article
RosettaCM for antibodies with very long HCDR3s and low template availability.
- Published in:
- Proteins, 2021, v. 89, n. 11, p. 1458, doi. 10.1002/prot.26166
- By:
- Publication type:
- Article
Author Correction: Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.706757
- By:
- Publication type:
- Article
Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24649-w
- By:
- Publication type:
- Article
Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 602, p. 1, doi. 10.1126/scitranslmed.abg6128
- By:
- Publication type:
- Article
Antibody affinity versus dengue morphology influences neutralization.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009331
- By:
- Publication type:
- Article
ClonoMatch: a tool for identifying homologous immunoglobulin and T-cell receptor sequences in large databases.
- Published in:
- Bioinformatics, 2020, v. 36, n. 24, p. 5695, doi. 10.1093/bioinformatics/btaa1028
- By:
- Publication type:
- Article
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19096-y
- By:
- Publication type:
- Article
Inappropriate Citation of Vaccine Article.
- Published in:
- 2020
- By:
- Publication type:
- letter
Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 8, p. 1, doi. 10.1371/journal.ppat.1008743
- By:
- Publication type:
- Article
PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST.
- Published in:
- BMC Bioinformatics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12859-020-03649-5
- By:
- Publication type:
- Article
Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0235713
- By:
- Publication type:
- Article
Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.
- Published in:
- Science Immunology, 2020, v. 5, n. 49, p. 1, doi. 10.1126/sciimmunol.aba4902
- By:
- Publication type:
- Article
Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 5, p. 1, doi. 10.1371/journal.ppat.1008517
- By:
- Publication type:
- Article
Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Correlation of clinical and chest radiograph findings in pediatric submersion cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vaccine innovations for emerging infectious diseases—a symposium report.
- Published in:
- Annals of the New York Academy of Sciences, 2020, v. 1462, n. 1, p. 14, doi. 10.1111/nyas.14235
- By:
- Publication type:
- Article
Multi-state design of flexible proteins predicts sequences optimal for conformational change.
- Published in:
- PLoS Computational Biology, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.pcbi.1007339
- By:
- Publication type:
- Article
Correction: Tissue-Specific Expressed Antibody Variable Gene Repertoires.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Broad dengue neutralization in mosquitoes expressing an engineered antibody.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 1, p. 1, doi. 10.1371/journal.ppat.1008103
- By:
- Publication type:
- Article
Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures.
- Published in:
- BMC Bioinformatics, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12859-019-3281-8
- By:
- Publication type:
- Article
Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
2593. Human Monoclonal Antibodies Potently Neutralize Enterovirus D68 in both a Clade-Specific and -Independent Manner.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S901, doi. 10.1093/ofid/ofz360.2271
- By:
- Publication type:
- Article
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.
- Published in:
- Science Immunology, 2019, v. 4, n. 35, p. 1, doi. 10.1126/sciimmunol.aaw6647
- By:
- Publication type:
- Article
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09732-7
- By:
- Publication type:
- Article